Pseudotumor cerebri risk factors

Jump to navigation Jump to search

Pseudotumor cerebri Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating pseudotumor cerebri from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudotumor cerebri risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudotumor cerebri risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudotumor cerebri risk factors

CDC on Pseudotumor cerebri risk factors

Pseudotumor cerebri risk factors in the news

Blogs on Pseudotumor cerebri risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pseudotumor cerebri risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Risk Factors

The most potent risk factors in the development of IHH are:

Common risk factors

Age and gender

Most of the IIH cases happen in women in child bearing age (9 uptodate), but it can also happens in children and old adult with male gender. In prepubertal age the gender is not an important risk factor and in old patients the percent of affected males was higher than females.(16-29 uptodate)

Obesity

Some evidences suggest that onesity can increase intra abdominal and intra cranial pressure and have a role in pathogenesis of IHH.(89)

Positive family history (15 upto)
Medications
  • growth hormones: Development of IIH in result of GH therapy mostly happens in one year of medication initiation, but it can also develop after several years of treatment. witj stoping the use of GH, symptoms of IIH will improve.(35-38 upto)
  • Minocycline(39)
  • Doxycycline(39)
  • vitamin A(39)
Systemib illness
  • Addison disease(68)
  • Hypoparathyroidism(69)
  • Sever anemia(14)
  • Sleep apnea(14)
  • SLE(75)
  • Behcet’s syndrome(78)
  • Polycystic ovary syndrome(80)
  • Coagulation disorders(80)
  • Uremia(84)

Less common risk factors

drugs such as:

  • thyroxin(23)
  • corticosteroid withdrawal(29)
  • lithium(60)
  • nalidixic acid(24)
  • nitrofurantoin(65)

References

Template:WH Template:WS